Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.

MLA

Kim, Nayoung, et al. “Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.” Anticancer Research, vol. 36, no. 11, Nov. 2016, pp. 6109–16. EBSCOhost, https://doi.org/10.21873/anticanres.11201.

APA

Kim, N., Lee, S. H., Son, J. H., Lee, J. M., Kang, M.-J., Kim, B. H., Lee, J.-S., Ryu, J. K., & Kim, Y.-T. (2016). Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells. Anticancer Research, 36(11), 6109–6116. https://doi.org/10.21873/anticanres.11201

Chicago

Kim, Nayoung, Sang Hyub Lee, Jun Hyuk Son, Jae Min Lee, Min-Jung Kang, Bo Hye Kim, Jung-Su Lee, Ji Kon Ryu, and Yong-Tae Kim. 2016. “Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells.” Anticancer Research 36 (11): 6109–16. doi:10.21873/anticanres.11201.